Related Experiment Video
Updated: Jan 6, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Pathophysiology of Atopic Dermatitis and Psoriasis: Implications for Management in Children
Raj Chovatiya1, Jonathan I Silverberg2
1Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. raj.chovatiya@gmail.com.
Insights
Atopic dermatitis (AD) and psoriasis are chronic inflammatory skin diseases. New insights into immune pathways are revolutionizing treatments, offering novel topical and systemic therapies for improved patient quality of life.
Area of Science:
- Dermatology
- Immunology
- Pathophysiology
Background:
- Atopic dermatitis (AD) and psoriasis are chronic inflammatory skin diseases with significant patient burden.
- Both conditions involve immune dysregulation, skin barrier issues, genetics, and environmental factors.
Purpose of the Study:
- To review the complex pathophysiology of AD and psoriasis.
- To discuss current and emerging therapeutic strategies for these conditions.
Main Methods:
- Literature review of pathophysiology and treatment options for AD and psoriasis.
- Analysis of immune pathways, including T-helper cell involvement.
Main Results:
- AD and psoriasis share common etiological factors but differ in specific immune pathways (Th2 in AD, Th1/Th17 in psoriasis).
- Therapeutic approaches have evolved from broad anti-inflammatories to targeted therapies.
Conclusions:
- Understanding specific immune dysregulation in AD and psoriasis has led to a therapeutic revolution.
- Novel topical and systemic treatments are available and under investigation, offering improved management options.
Abstract:
Atopic dermatitis (AD) and psoriasis are chronic inflammatory skin diseases associated with a significant cutaneous and systemic burden of disease as well as a poor health-related quality of life. Here, we review the complex pathophysiology of both AD and psoriasis and discuss the implications for treatment with current state-of-the-art and emerging topical and systemic therapies. Both AD and psoriasis are caused by a complex combination of immune dysregulation, skin-barrier disruption, genetic factors, and environmental influences. Previous treatments for both diseases were limited to anti-inflammatory agents that broadly suppress inflammation. Emerging insights into relevant pathways, including recognition of the role of T-helper type 2 driven inflammation in AD and T-helper 1 and 17 driven inflammation in psoriasis, have led to a therapeutic revolution. There are a number of novel treatment options available for AD and psoriasis with many more currently under investigation.
More Related Videos
06:47Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation